Abbott develops healthcare technologies across medical devices, diagnostics, nutrition and biowearables, including FreeStyle Libre glucose monitoring and Lingo.
Abbott is a healthcare technology company whose products span nutrition, biowearables and metabolic monitoring - areas of direct interest to those working in fitness and performance. Its Lingo biowearable is designed to help people understand their health and wellness, while the FreeStyle Libre continuous glucose monitoring system has changed how diabetes is managed. The company also produces science-based nutrition products intended to support growth and recovery at every stage of life.
Beyond consumer health, Abbott develops cardiovascular medical devices, including AVEIR DR, a leadless pacemaker for cardiac rhythm management, as well as diagnostics and blood testing. Its diagnostic work includes the first licensed HIV blood test. The company's technical domains cover continuous glucose monitoring, cardiovascular devices, diagnostics and blood testing, nutrition science, biowearables, leadless pacemaker technology and pharmaceutical manufacturing.
Founded in Chicago in 1888, Abbott now employs 115,000 people and operates in more than 160 countries. It has been named to Fortune's Most Admired Companies list every year since 1984. The company describes its purpose as helping people live healthier, fuller lives, with an emphasis on breakthrough science and on addressing pressing health needs.
